Task B21: In Vitro Assessment for Antimicrobial Activity Support

任务 B21：抗菌活性支持的体外评估

• 批准号: 10928401
• 负责人: JUSTIN JULANDER
• 金额: $ 13.83万
• 依托单位: UTAH STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-05 至 2024-09-04
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10928401
• 关键词: Antiviral Agents; Biological Assay; Cell Line; Contracts; Coxsackie Viruses; Development; Echo Viruses; Hepatitis B; Human; Human poliovirus; In Vitro; Infrastructure; Maintenance; Measles; Respiratory syncytial virus; Viral; Virus; antimicrobial; in vitro testing

This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.

该合同提供潜在抗病毒药物的体外测试、培养病毒所需的病毒储液和细胞系的维护以及相关测定的开发。